CLRB — CELLECTAR BIOSCIENCES INC
As of Q2 2026, 6 SEC-registered investment managers reported holding CLRB (CELLECTAR BIOSCIENCES INC) in their latest 13F filings, with a combined reported value of $824.36K across 296.53K shares. That is +338.1% by share count (+228.84K shares) versus the previous quarter, while reported value moved +379.4%. Ownership is concentrated: the five largest holders account for 99.8% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 1 added to existing stakes, 1 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CLRB is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Balyasny Asset Management history | Q2 2026 | 220.00K | $611.60K | 0.00% | New |
| Vanguard Group history | Q4 2025 | 89.12K | $262.90K | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 53.35K | $148.32K | 0.00% | Add |
| Renaissance Technologies history | Q3 2025 | 24.90K | $139.44K | 0.00% | New |
| Citadel Advisors history | Q3 2025 | 18.53K | $103.75K | 0.00% | New |
| BNY Mellon history | Q2 2022 | 121.11K | $49.00K | 0.00% | Reduce |
| Two Sigma Investments history | Q4 2021 | 65.09K | $43.00K | 0.00% | Add |
| Franklin Resources history | Q2 2022 | 103.64K | $42.00K | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 14.84K | $41.25K | 0.00% | New |
| T. Rowe Price Associates history | Q4 2021 | 41.70K | $28.00K | 0.00% | Hold |
| BlackRock Inc history | Q2 2026 | 4.74K | $13.16K | 0.00% | Hold |
| PNC Financial Services history | Q3 2021 | 10.00K | $9.00K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 3.09K | $8.60K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 510 | $1.42K | 0.00% | Hold |
| Bank of America Corp history | Q4 2025 | 36 | $106 | 0.00% | Add |
| Citigroup Inc history | Q3 2025 | 19 | $106 | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q1 2026 | 10 | $25 | 0.00% | New |
| Wells Fargo & Co history | Q2 2022 | 395 | $0 | — | Add |
New Positions (Q2 2026)
- Balyasny Asset Management 220.00K sh · $611.60K
- Northern Trust Corp 14.84K sh · $41.25K
Fully Exited (vs previous quarter)
- Fidelity Management & Research (FMR) sold 10 sh · $25
Fund Position History — shares by quarter (top 18 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Balyasny Asset Management | — | — | — | — | — | — | — | — | 220.00K |
| Geode Capital Management | 441.88K | 441.88K | 441.88K | 444.42K | 14.44K | 24.89K | 28.64K | 52.78K | 53.35K |
| Northern Trust Corp | 95.44K | 95.44K | 95.44K | 95.44K | — | — | — | — | 14.84K |
| BlackRock Inc | — | — | — | — | 4.74K | 4.75K | 4.75K | 4.75K | 4.74K |
| UBS Group AG | 11.50K | 51.96K | 16.50K | 39.64K | 3.62K | 908 | 2.60K | 9.65K | 3.09K |
| Morgan Stanley | 578.36K | 276.98K | 22 | 19 | 510 | 510 | 510 | 510 | 510 |
| Citadel Advisors | — | 164.58K | — | 68.99K | — | 18.53K | — | — | — |
| Fidelity Management & Research (FMR) | 1 | — | — | — | — | — | — | 10 | — |
| Renaissance Technologies | 447.07K | 119.93K | 126.80K | 166.50K | — | 24.90K | — | — | — |
| Bank of America Corp | — | 106 | — | 1.50K | 2 | 27 | 36 | — | — |
| Citigroup Inc | — | — | — | — | 1 | 19 | — | — | — |
| Vanguard Group | 1.96M | 1.96M | 1.75M | 1.75M | 56.34K | 65.17K | 89.12K | — | — |
| Two Sigma Investments | 46.63K | 65.09K | — | — | — | — | — | — | — |
| BNY Mellon | 121.74K | 121.74K | 121.74K | 121.11K | — | — | — | — | — |
| Franklin Resources | 142.40K | 142.40K | 142.40K | 103.64K | — | — | — | — | — |
| PNC Financial Services | 10.00K | — | — | — | — | — | — | — | — |
| T. Rowe Price Associates | 41.70K | 41.70K | — | — | — | — | — | — | — |
| Wells Fargo & Co | 3.35K | 364 | 365 | 395 | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details